Minjoon Kim

Mr. Minjoon Kim

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
MKMinjoon Kim
Minjoon Kim
HKHae Won Kim
Hae Won Kim
KKKyeongEui Kim
KyeongEui Kim
JCJaemin Cho
Jaemin Cho
WJWoon Kyung Jeong
Woon Kyung Jeong
SBSung Uk Bae
Sung Uk Bae
Objectives: The dietary inflammatory index (DII), a validated tool for assessing the inflammatory potential of diet, has been widely identified as a significant risk factor for colorectal cancer (CRC). However, its role as a prognostic factor for CRC remains unexplored. This study examined the impact of preoperative dietary inflammation on clinical and oncologic outcomes following CRC surgery. Methods: The study population consisted of 126 patients who had surgical procedures for CRC and completed a food frequency questionnaire (FFQ) preoperatively between January 2018 and June 2020. Results: An optimal DII cut-off value of 0.90182 was used to categorize patients into the high-DII (n = 28) and low-DII (n = 98) groups. The high-DII group exhibited an older age (71.5 vs. 67.0, p = 0.020) and a significantly higher complication risk within 30 days postoperatively than the low-DII group (57.1% vs. 35.7%, p = 0.042). Other perioperative clinical outcomes did not demonstrate any significant differences between the two groups. The 5-year overall survival (OS) rates were 90.4% and 41.3% in the low-DII and high-DII groups, respectively, in univariate survival analysis (p = 0.044). However, no statistical difference was observed in the disease-free survival (DFS) rate. In the multivariate survival analysis, low-DII (hazard ratio [HR]: 0.118; 95% confidence interval [CI]: 0.023–0.613, p = 0.011) and M1 stage (HR: 10.910; 95% CI: 1.491–79.847, p = 0.019) were identified as independent prognostic factors for OS, while perineural invasion (HR: 3.495; 95% CI: 1.059–11.533, p = 0.040) served as an independent prognostic factor for DFS. Conclusions: A high preoperative DII score, indicative of an inflammatory dietary pattern, was correlated with increased postoperative complications and functioned as an independent prognostic indicator for OS.

26 September 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
JKJaeyoung Kang
Jaeyoung Kang
SKSanghoon Kim
Sanghoon Kim
DSDa In Shin
Da In Shin
MKMinjoon Kim
Minjoon Kim
WJWoon Kyung Jeong
Woon Kyung Jeong
SBSung Uk Bae
Sung Uk Bae
Background and Aims: Postoperative recovery of body composition in patients with gastric cancer (GC) and colorectal cancer (CRC) is a complex and dynamic process. However, longitudinal recovery patterns across multiple physiological domains remain incompletely characterized. This study aimed to describe longitudinal changes in body composition over 12 months after curative surgery in patients with GC and CRC. Methods: This prospective longitudinal study evaluated serial changes in body composition parameters, including body weight, skeletal muscle index (SMI), phase angle (PhA), and the extracellular water to total body water ratio (ECW/TBW), from the preoperative period to 12 months after curative surgery in 138 patients, comprising 61 patients with GC and 77 patients with CRC. Results: Distinct and time-dependent recovery patterns were observed across body composition domains. Body weight and SMI gradually declined after surgery, reaching their lowest levels at approximately 3 months postoperatively, followed by partial recovery at 6 and 12 months; however, complete restoration to preoperative values was not achieved in several subgroups. In contrast, PhA declined abruptly on postoperative day 1, while ECW/TBW peaked at the same time point, representing the most prominent early postoperative changes in these parameters. Descriptive subgroup patterns suggested less complete recovery of SMI, PhA, and ECW/TBW among elderly, low skeletal muscle mass, advanced-stage, and chemotherapy-treated patients. Patients with low skeletal muscle mass showed persistently lower SMI values, whereas advanced-stage and chemotherapy-treated patients appeared to show slower normalization of PhA and ECW/TBW. Conclusions: Postoperative changes in body composition appeared to occur asynchronously across multiple physiological domains in patients with gastric and colorectal cancer. Several clinically vulnerable subgroups, including older patients, patients with low skeletal muscle mass or advanced-stage disease, and patients who received chemotherapy, showed descriptive patterns suggestive of less complete recovery. Serial body composition assessment over an extended follow-up period may help characterize postoperative changes and provide a basis for future hypothesis-driven studies.

20 April 2026 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
MKMinjoon Kim
Minjoon Kim
HLHye Won Lee
Hye Won Lee
DSDa In Shin
Da In Shin
WJWoon Kyung Jeong
Woon Kyung Jeong
SBSeong Kyu Baek
Seong Kyu Baek
SBSung Uk Bae
Sung Uk Bae
Despite widespread adoption of neoadjuvant chemoradiotherapy (nCRT), locally advanced rectal cancer (LARC) shows highly heterogeneous treatment responses and survival outcomes. Pretreatment biopsy-derived Immunoscore (ISB) and the pan-immune-inflammation value (PIV) reflect local and systemic inflammation, respectively, and each has demonstrated prognostic value in LARC. However, the prognostic impact of integrating ISB with PIV has not been evaluated. This study aimed to determine whether combining ISB and PIV to jointly assess local and systemic inflammatory profiles improves risk stratification in LARC. We retrospectively analyzed 65 patients with LARC who underwent nCRT and surgery. ISB was assessed using pretreatment endoscopic biopsy specimens immunohistochemically stained for CD3 and CD8. Patients were stratified into three groups according to their combined PIV–ISB profiles: Group 1 (PIV-High and ISB-Low), Group 2 (mixed-risk patterns), and Group 3 (PIV-Low and ISB-Intermediate/High). Group 1 exhibited higher C-reactive protein levels than those of Group 3 (p = 0.043). Five-year overall survival (OS) rates were 44.4%, 78.1%, and 82.7% in Groups 1, 2, and 3, respectively (p = 0.007), whereas disease-free survival (DFS) did not differ significantly (p = 0.186). In multivariate analysis, Group 2 independently predicted OS (vs. Group 1; hazard ratio [HR] 0.190, 95% confidence interval [CI] 0.043–0.831, p = 0.027), while lymphovascular invasion predicted OS (HR 6.386, 95% CI 1.412–28.882, p = 0.016) and DFS (HR 3.683, 95% CI 1.272–10.664, p = 0.016). Integrating ISB and PIV provides improved prognostic stratification in patients with LARC treated with nCRT, identifying a high-risk subgroup with markedly inferior OS.